Half of the existing 3ml...Huons, Low-Dose PDRN Injection Amotalex Juice 1.5ml
Jul 28, 2025
|
It has released 'Amotalexju 1.5ml', which halves the capacity compared to the existing 3ml formulation.
Amotalex liquor is an injection containing PDRN extracted from salmon-derived deoxyribonucleic acid (DNA). PDRN injections are DNA-based injections that help heal and recover human tissue, and are used to treat damage and pain in joints, tendons, and ligaments, as well as burns and wounds.
Huons explained that through the launch of its low-dose product, it has launched 1.5 ml of Amotalex to meet the needs of the PDRN market and provide a more suitable treatment solution for patients.
Since vial products are discarded after opening, the use of a 1.5ml formulation can minimize the waste of the remaining amount of drugs that occurred when using the existing 3ml formulation. Accordingly, it is expected that the utilization of new products 'Amotalexju 1.5ml' will be high in various medical fields.
"This launch of low-dose PDRN injection products is a measure that actively reflects the voice of the medical field," a Huons official said. "We will continue to actively consider launching additional formulations that can meet the needs of medical staff." he said.
This article was translated by Naver AI translator.
